Active Wound Care Market Size (2024 - 2029)

Active Wound Care Market Analysis

The Active Wound Care Market size is estimated at USD 2.89 billion in 2024, and is expected to reach USD 3.78 billion by 2029, growing at a CAGR of 4.64% during the forecast period (2024-2029).

The factors driving the market's growth include the high prevalence of acute and chronic wounds, the rising number of innovative product launches, and the increasing number of surgeries.

The rise in wound-related hospitalizations owing to an increase in surgical and pressure ulcer-prone wounds is expected to fuel the market growth. For instance, according to an article published by the Elsevier Journal in August 2022, critical care patients were at higher risk of developing pressure ulcers owing to their immobility, reliance on pressure relief devices, and regular position changes. Therefore, the high number of patients who are likely to develop pressure ulcers raises the demand for active wound care products for faster healing, propelling the market growth.

The prevalence of chronic diseases like diabetes, obesity, and cardiovascular conditions often leads to complications such as diabetic foot ulcers and arterial ulcers, which drive market growth. For instance, according to the 2022 data published by the International Diabetes Federation, about 643 million people are expected to suffer from diabetes globally by 2030. This number is projected to reach 784 million by 2045. The increase in the diabetic population raises the risk of developing diabetic foot ulcers, increasing the demand for ulcer dressings and skin substitutes that are effective in healing foot ulcers, thereby contributing to market growth.

The rising number of innovative product launches related to active wound care, specifically in the areas of biomaterials, skin substitutes, and growth factors, is expected to drive market growth during the forecast period. For instance, in May 2022, the Technical University of Munich (TUM) in Germany developed a new kind of film dressing using mucin biomolecules for the protection of wounds. This dressing is also incorporated with active pharmaceutical ingredients to accelerate wound healing, expel bacteria, inhibit inflammation, and finally decompose on the skin by itself.

In June 2022, Collagen Matrix Inc. received the US Food and Drug Administration approval for a new fibrillar collagen wound dressing. The Collagen Matrix Fibrillar Collagen Wound Dressing is an absorbent microfibrillar matrix used to treat wounds that moderately exude fluid and control mild bleeding. Therefore, the rising number of biomaterial-based wound care products by prominent players is projected to drive market growth during the forecast period.

Procedures like breast reconstruction, facial reconstruction, and body contouring surgeries are on the rise, often involving extensive tissue manipulation and reconstruction. For instance, according to the Cosmetic Surgery Statistics 2024 report, about 2 million surgical and non-surgical procedures are performed annually in the United States. In addition, an estimated 350 thousand breast augmentation procedures are expected to be performed in the United States in 2024. These procedures require advanced wound care products to promote healing and optimize cosmetic outcomes, driving the active wound care market's growth. 

Hence, factors such as the increasing prevalence of acute and chronic wounds, the rising number of innovative product launches, and the increasing number of surgeries are projected to drive market growth during the forecast period.

Active Wound Care Industry Segmentation

As per the scope of the report, active wound care includes wound dressing products used to remove damaged tissue or skin and help accelerate the growth of new tissues. Active wound care promotes rapid healing by removing the traumatic or infected skin or tissues surrounding the healthy tissues. The chances of getting an infection are reduced with such procedures. The chances of acquiring side effects are also comparatively low as the procedure involves the removal of infected tissues.

The active wound care market is segmented by product, end-user, application, and geography. By product, the market is segmented into biomaterials, skin substitutes, and growth factors. By end user, the market is segmented into hospitals, clinics, and home healthcare. By application, the market is segmented into chronic wounds and acute wounds. By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The report offers market sizes in value terms (USD) for all the above-mentioned segments.